Jobs in the legal cannabis industry are coming by the hundreds of thousands and there’s no sign of that halting.
Category: Kight On Cannabis
FDA and AHPA Convey Similar Message to Cannabis and CBD Industry
The “wild west” days of manufacturing and selling cannabis products outside the sphere of regulatory influence are rapidly coming to an end.
Why is the VA Denying Home Loans to Veterans Who Work in the Marijuana Industry? (Guest Post)
The Department of Veterans Affairs has “an unpublished policy” stating that the office does not consider employment in industries related to marijuana as either reliable or stable. These are among the two most important criteria for determining creditworthiness and who qualifies to purchase a home.
Smokable Hemp Sparks a Firestorm
This article discusses the reasons for smokable hemp’s rapid rise in popularity, why the future of smokable hemp is vital to the hemp industry at large, and the ways in which its legal status is under attack in several states.
North Carolina Hemp Bill Could Eliminate Smokable Hemp- Call to Action
The SBI contends that since hemp flower and marijuana flower can sometimes be indistinguishable, SB 315 would effectively legalize marijuana legal in North Carolina. We were not persuaded by this, or any of the other arguments SBI made that sought to limit the legal status of hemp in North Carolina.
DHL Will Not Ship Lawful Hemp or CBD Products
My client’s interaction with DHL reiterates my view that it is usually best to ship hemp and hemp products through the US Postal Service.
USPS Publishes New Guidelines for Mailing Hemp and Hemp Products
On June 6, an update from the United States Postal Service (USPS) arrived with new and more straightforward guidelines for mailing hemp and CBD in the United States.
Texas Passes Hemp and CBD Law- Effective Immediately
Texas finally came around and enacted House Bill 1325 (HB1325), which regulates hemp production in the state. The law went into effect last night.
Rod Quoted by Time Magazine About FDA Hearing on CBD
I spoke with Elijah Wolfson of Time Magazine about CBD after the FDA hearing. We spoke about several issues, including how to regulate CBD for mass market consumption while protecting the integrity of the clinical drug trials process.